Effect of chronic periodontitis on oxidative status in patients with rheumatoid arthritis

Journal of Periodontology

Volumn 84, Issue 6, 2013, Pages 785-792

  Sezer, Ufuk ^a   Erciyas, Kamile ^a   Üstün, Kemal ^a   Pehlivan, Yavuz ^b   Şenyurt, Süleyman Ziya ^a   Aksoy, Nurten ^c   Tarakçioǧlu, Mehmet ^a   Taysi, Seyithan ^a   Onat, Ahmet Mesut ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Gaziantep Faculty of Medicine   (Turkey)

^c HARRAN UNIVERSITY   (Turkey)

Author keywords

Oxidative stress; Periodontitis

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CARBOXYLESTERASE; CERULOPLASMIN; DIPEPTIDASE; LIPID PEROXIDE; OXIDIZING AGENT; PROLINE DIPEPTIDASE; SCAVENGER; THIOL DERIVATIVE;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PHYSIOLOGY; RHEUMATOID ARTHRITIS;

ADULT; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; CERULOPLASMIN; CHRONIC PERIODONTITIS; CROSS-SECTIONAL STUDIES; DIPEPTIDASES; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; SULFHYDRYL COMPOUNDS;

EID: 84878629336     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120179     Document Type: Article

References (57)

1. American Academy of Periodontology. The pathogenesis of periodontal diseases (position paper). J Periodontol 1999;70:457-470.
2. Chapple IL. Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol 1997;24: 287-296.
3. Sezer U, Cicxek Y, Canakcxi CF. Increased salivary levels of 8-hydroxydeoxyguanosine may be a marker for disease activity for periodontitis. Dis Markers 2012; 32:165-172.
4. Ohnishi T, Bandow K, Kakimoto K, Machigashira M, Matsuyama T, Matsuguchi T. Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes. J Periodontal Res 2009;44:43-51.
5. Ekuni D, Tomofuji T, Sanbe T, et al. Periodontitisinduced lipid peroxidation in rat descending aorta is involved in the initiation of atherosclerosis. J Periodontal Res 2009;44:434-442.
6. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol 2000;27: 267-272.
7. Winrow VR, Winyard PG, Morris CJ, Blake DR. Free radicals in inflammation: Second messengers and mediators of tissue destruction. Br Med Bull 1993;49: 506-522.
8. Ostrakhovitch EA, Afanas'ev IB. Oxidative stress in rheumatoid arthritis leukocytes: Suppression by rutin and other antioxidants and chelators. Biochem Pharmacol 2001;62:743-746.
9. Jira W, Spiteller G, Richter A. Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids 1997;87:81-89.
10. Esen C, Alkan BA, Kirnap M, Akgül O, Isxikoǧlu S, ErelO. The effects of chronic periodontitis and rheumatoid arthritis on serum and gingival crevicular fluid total antioxidant/oxidant status and oxidative stress index. J Periodontol 2012;83:773-779.
11. Coaccioli S, Panaccione A, Biondi R, et al. Evaluation of oxidative stress in rheumatoid and psoriatic arthritis and psoriasis. Clin Ter 2009;160:467-472.
12. Altindag O, Karakoc M, Kocyigit A, Celik H, Soran N. Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem 2007;40: 167-171.
13. Sarban S, Kocyigit A, Yazar M, Isikan UE. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005;38:981-986.
14. Nurcombe HL, Bucknall RC, Edwards SW. Activation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:237-242.
15. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-285.
16. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38:1103-1111.
17. Harma M, Harma M, Erel O. Oxidative stress in women with preeclampsia. Am J Obstet Gynecol 2005;192: 656-657, author reply 657.
18. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998;44:2313-2319.
19. Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999;300:58-62.
20. Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: Application to iminodipeptiduria. Clin Chim Acta 1982;125:193-205.
21. Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997;67: 166-175.
22. Brosset B, Myara I, Fabre M, Lemonnier A. Plasma prolidase and prolinase activity in alcoholic liver disease. Clin Chim Acta 1988;175:291-295.
23. Yildiz A, Demirbag R, Yilmaz R, et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008;19:319-325.
24. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
25. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-48.
26. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
27. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993;121:257-262.
28. Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992;30:391-395.
29. Eckerson HW, Wyte CM, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35:1126-1138.
30. Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem 1952;199:91-95.
31. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
32. Flemmig TF. Periodontitis. Ann Periodontol 1999;4: 32-38.
33. Nishida N, Tanaka M, Hayashi N, et al. Determination of smoking and obesity as periodontitis risks using the classification and regression tree method. J Periodontol 2005;76:923-928.
34. Pers JO, Saraux A, Pierre R, Youinou P. Anti-TNFalpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Periodontol 2008;79:1645-1651.
35. Howell TH. Blocking periodontal disease progression with anti-inflammatory agents. J Periodontol 1993;64 (Suppl. 8)828-833.
36. Abou Sulaiman AE, Shehadeh RM. Assessment of total antioxidant capacity and the use of vitamin C in the treatment of non-smokers with chronic periodontitis. J Periodontol 2010;81:1547-1554.
37. Akalin FA, Baltacioǧlu E, Alver A, Karabulut E. Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in pregnant women with chronic periodontitis. J Periodontol 2009; 80:457-467.
38. Wei D, Zhang XL, Wang YZ, Yang CX, Chen G. Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust Dent J 2010;55:70-78.
39. Akalin FA, Baltacioǧlu E, Alver A, Karabulut E. Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol 2007;34: 558-565.
40. Ozkan Y, Yardým-Akaydýn S, Sepici A, Keskin E, Sepici V, Simsek B. Oxidative status in rheumatoid arthritis. Clin Rheumatol 2007;26:64-68.
41. Couto D, Ribeiro D, Freitas M, Gomes A, Lima JL, Fernandes E. Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine. Redox Rep 2010;15:259-267.
42. Kladna A, Aboul-Enein HY, Kruk I, Lichszteld K, Michalska T. Scavenging of reactive oxygen species by some nonsteroidal anti-inflammatory drugs and fenofibrate. Biopolymers 2006;82:99-105.
43. Hassan SZ, Gheita TA, Kenawy SA, Fahim AT, El-Sorougy IM, Abdou MS. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: Relationship to disease manifestations and activity. Int J Rheum Dis 2011;14:325-331.
44. Karincaoglu Y, Batcioglu K, Erdem T, Esrefoglu M, Genc M. The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J Oral Pathol Med 2005;34:7-12.
45. Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002;21:200-204.
46. Louro MO, Cocho JA, Mera A, Tutor JC. Immunochemical and enzymatic study of ceruloplasmin in rheumatoid arthritis. J Trace Elem Med Biol 2000;14: 174-178.
47. Isik A, Koca SS, Ustundag B, Celik H, Yildirim A. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin Rheumatol 2007;26:342-348.
48. Baskol G, Demir H, Baskol M, et al. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 2005; 38:951-955.
49. Seven A, Güzel S, Aslan M, Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem 2008;41:538-543.
50. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998;39:1529-1542.
51. Oztürk HS, Cimen MY, Cimen OB, Kacxmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999; 19:35-37.
52. Sklodowska M, Gromadzinska J, Biernacka M, et al. Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clin Exp Rheumatol 1996;14:433-439.
53. Olivieri O, Girelli D, Trevisan MT, et al. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition and antioxidant enzymes in patients with rheumatoid arthritis. J Rheumatol 1991;18: 1263-1264.
54. Ortiz P, Bissada NF, Palomo L, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009;80: 535-540.
55. Ribeiro J, Leaö A, Novaes AB. Periodontal infection as a possible severity factor for rheumatoid arthritis. J Clin Periodontol 2005;32:412-416.
56. Sezer U, Kara MI, Erciyas K, et al. Protective effects of ginkgo biloba extract on ligature-induced periodontitis in rats. Acta Odontol Scand 2012;70: 194-201.
57. Lee JH, Kim GH. Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis. J Food Sci 2010;75: H212-H217.